ArticleFrontiers in medicine2026

TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism.

Jiongzheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.